The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Fall 2021 RFA: Promoting Diversity, Equity and Inclusion in Parkinson’s Disease Research, 2022Preventing Fractures in Parkinson’s Disease by Identifying Barriers to Care and Social Determinants of Health
Study Rationale: Compared with the general population, people with Parkinson’s disease (PD) are more likely to fall and break a bone as a result of disease-related motor issues, such as difficulty...
-
Outcome Measures, 2022Improving the generalizability and robustness of MRI-derived biomarkers of Parkinson's Disease through analytical and data variability evaluations
Study Rationale: Medical imaging is a promising technique to help with the early diagnosis, understanding, and treatment of Parkinson's disease. Indeed, using advanced image acquisition techniques and...
-
Fall 2021 RFP: Outcome Measures, 2022Using RNA from Extracellular Vesicles to Monitor RNA Changes in the Brain
Study Rationale: Our understanding of Parkinson’s disease (PD) would be significantly improved if we had a way to directly monitor disease development and progression in the brain. One approach is to...
-
Diversity, Equity and Inclusivity in Parkinson's research, 2022Understanding the Progression of Motor and Non-motor Symptoms and Functional Mobility of Māori and Pacific Peoples in New Zealand
Study Rationale: In this study, we will work with two underrepresented groups in Aotearoa, New Zealand, the Māori and Pacific peoples. By better understanding the clinical presentation of Parkinson’s...
-
Fall 2021 RFP: Outcome Measures, 2022Development of Standardized Measurements for Monitoring the Progression of Parkinson’s Disease via MRI
Study Rationale: One of the difficulties in research towards new treatments in Parkinson’s disease (PD) is the diversity of disease presentations and the lack of tools to measure the effect of a...
-
, 2022Studying the Epidemiology of Parkinson’s Disease in Latin America: Learning from Underrepresented Populations
Study Rationale: Initial evidence has shown that the global distribution of Parkinson’s disease (PD) may vary; however, little is known about the prevalence of PD across large parts of the world. This...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.